ArticleTranslational lung cancer research2024

Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion.

Kakeru Hisakane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.